Publications by authors named "Bryan R Luce"

Claim this Profile
H
How different is research done by the Patient-centered Outcomes Research Institute, and what difference does it make?
Bryan R Luce, Jason C Simeone

J Comp Eff Res· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Value Challenge: Examining the Transformative Strategies to Measure or Evaluate the Value of Health Care Interventions.
Bryan R Luce

Value Health· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using Bayesian Adaptive Trial Designs for Comparative Effectiveness Research: A Virtual Trial Execution.
Bryan R Luce, Jason T Connor, Kristine R Broglio, C Daniel Mullins, K Jack Ishak

Ann Intern Med· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics and temporal trends in patient registries: focus on the life sciences industry, 1981-2012.
Karin Travers, Rachel H Sallum, Meghan D Burns, Charles E Barr, Mary S Beattie, Bryan R Luce

Pharmacoepidemiol Drug Saf· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Do Bayesian adaptive trials offer advantages for comparative effectiveness research? Protocol for the RE-ADAPT study.
Jason T Connor, Bryan R Luce, Kristine R Broglio, K Jack Ishak, C Daniel Mullins

Clin Trials· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Principles for planning and conducting comparative effectiveness research.
Bryan R Luce, Michael F Drummond, Robert W Dubois, Peter J Neumann, Bengt Jönsson

J Comp Eff Res· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of private industry in pragmatic comparative effectiveness trials.
Don P Buesching, Bryan R Luce, Marc L Berger

J Comp Eff Res· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bayesian meta-analyses for comparative effectiveness and informing coverage decisions.
Scott M Berry, K Jack Ishak, Bryan R Luce, Donald A Berry

Med Care· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EBM, HTA, and CER: clearing the confusion.
Bryan R Luce, Michael Drummond, Bengt Jönsson, Peter J Neumann, J Sanford Schwartz

Milbank Q· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Value of biologic therapy: a forecasting model in three disease areas.
L Clark Paramore, Craig A Hunter, Bryan R Luce, Robert J Nordyke, R J Halbert

Curr Med Res Opin· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Are Key Principles for improved health technology assessment supported and used by health technology assessment organizations?

Int J Technol Assess Health Care· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Willingness to pay for cancer prevention.
Timothy L Hunt, Bryan R Luce, Matthew J Page, Robin Pokrzywinski

Pharmacoeconomics· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rethinking randomized clinical trials for comparative effectiveness research: the need for transformational change.
Bryan R Luce, Judith M Kramer, Steven N Goodman, Jason T Connor, Sean Tunis

Ann Intern Med· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Key principles for the improved conduct of health technology assessments for resource allocation decisions.
Michael F Drummond, J Sanford Schwartz, Bengt Jönsson, Bryan R Luce, Peter J Neumann

Int J Technol Assess Health Care· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of live attenuated influenza vaccine versus inactivated influenza vaccine among children aged 24-59 months in the United States.
Bryan R Luce, Kristin L Nichol, Robert B Belshe, Kevin D Frick, Su Xia Li

Vaccine· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can managed care organizations partner with manufacturers for comparative effectiveness research?
Bryan R Luce, L Clark Paramore, Bhash Parasuraman, Bengt Liljas, Gregory de Lissovoy

Am J Manag Care· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The return on investment in health care: from 1980 to 2000.
Bryan R Luce, Josephine Mauskopf, Frank A Sloan, Jan Ostermann, L Clark Paramore

Value Health· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic burden of heart failure: a summary of recent literature.
Won Chan Lee, Yoko E Chavez, Tim Baker, Bryan R Luce

Heart Lung· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient satisfaction with budesonide Turbuhaler versus triamcinolone acetonide administered via pressurized metered-dose inhaler in a managed care setting.
Kevin B Weiss, L Clark Paramore, Bengt Liljas, Dennis A Revicki, Bryan R Luce

J Asthma· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What will it take to make cost-effectiveness analysis acceptable in the United States?
Bryan R Luce

Med Care· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence based? Caveat emptor!
Earl P Steinberg, Bryan R Luce

Health Aff (Millwood)· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of budesonide administered via dry-powder inhaler versus triamcinolone acetonide administered via pressurized metered-dose inhaler for adults with persistent asthma in managed care settings.
Kevin B Weiss, Bengt Liljas, William Schoenwetter, Michael Schatz, Bryan R Luce

Clin Ther· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on Good Research Practices--Modeling Studies.
Milton C Weinstein, Bernie O'Brien, John Hornberger, Joseph Jackson, Magnus Johannesson, Bryan R Luce

Value Health· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect on social welfare of a switch of second-generation antihistamines from prescription to over-the-counter status: a microeconomic analysis.
Ya-Chen Tina Shih, Manishi Prasad, Bryan R Luce

Clin Ther· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis